Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyang Huang

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 3, 2015
[Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation]Dehui Zou, Wenyang Huang, Hong Liu, et al.
Oxidative Medicine and Cellular Longevity|January 10, 2022
Peptides Isolated from Yak Milk Residue Exert Antioxidant Effects through Nrf2 Signal PathwayFeiyan Yang, Xudong He, Tao Chen, et al.
Annals of Hematology|May 9, 2020
Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myelomaXiao Ding, Wenyang Huang, Yi Peng, et al.
Academic Radiology|July 6, 2024
Total Tumor ADC Histogram Analysis: A New Tool for Predicting High-Risk Cytogenetic Abnormalities in Multiple Myeloma PatientsJiao Li, Qin Wang, Junde Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2024
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell LymphomaJie Jin, Hong Cen, Keshu Zhou, et al.
Future Oncology (London, England)|June 30, 2023
More accurate prediction of treatment response than mean apparent diffusion coefficient value in multiple myeloma using whole body MRI histogram analysisQingyan Qi, Huazheng Dong, Xiaodong Ji, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 3, 2014
[Dose-intensive immunochemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of 29 newly diagnosed young patients with medium/high risk diffuse large B-cell lymphoma]Shuhua Yi, Wei Liu, Rui Lyu, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 13, 2023
Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR ImagingYuhan Gao, Qin Wang, Lu Zhang, et al.
Annals of Hematology|April 6, 2024
Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in ChinaLan Luo, Yang Jiao, Yan Li, et al.
Frontiers in Medicine|June 29, 2026
Disease characteristics, treatment, and outcomes in Chinese chronic lymphocytic leukemia patients following BTK inhibitor discontinuation: a multicenter real-world studyYuting Yan, Wei Wang, Xiaojing Yan, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 3, 2015
[Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation]Dehui Zou, Wenyang Huang, Hong Liu, et al.
Oxidative Medicine and Cellular Longevity|January 10, 2022
Peptides Isolated from Yak Milk Residue Exert Antioxidant Effects through Nrf2 Signal PathwayFeiyan Yang, Xudong He, Tao Chen, et al.
Annals of Hematology|May 9, 2020
Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myelomaXiao Ding, Wenyang Huang, Yi Peng, et al.
Academic Radiology|July 6, 2024
Total Tumor ADC Histogram Analysis: A New Tool for Predicting High-Risk Cytogenetic Abnormalities in Multiple Myeloma PatientsJiao Li, Qin Wang, Junde Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2024
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell LymphomaJie Jin, Hong Cen, Keshu Zhou, et al.
Future Oncology (London, England)|June 30, 2023
More accurate prediction of treatment response than mean apparent diffusion coefficient value in multiple myeloma using whole body MRI histogram analysisQingyan Qi, Huazheng Dong, Xiaodong Ji, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 3, 2014
[Dose-intensive immunochemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of 29 newly diagnosed young patients with medium/high risk diffuse large B-cell lymphoma]Shuhua Yi, Wei Liu, Rui Lyu, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 13, 2023
Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR ImagingYuhan Gao, Qin Wang, Lu Zhang, et al.
Annals of Hematology|April 6, 2024
Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in ChinaLan Luo, Yang Jiao, Yan Li, et al.
Frontiers in Medicine|June 29, 2026
Disease characteristics, treatment, and outcomes in Chinese chronic lymphocytic leukemia patients following BTK inhibitor discontinuation: a multicenter real-world studyYuting Yan, Wei Wang, Xiaojing Yan, et al.
Pageof 6